Lista de obras -

Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.

artículo científico publicado en 2017

Adverse effects after the use of JWH-210 - a case series from the EU Spice II plus project.

artículo científico publicado en 2016

Bad trip due to 25I-NBOMe: a case report from the EU project SPICE II plus

artículo científico publicado en 2017

Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines: An update comprising flunitrazolam, norflurazepam, and 4'-chlorodiazepam (Ro5-4864)

scientific article published on 05 February 2019

Cumyl-PEGACLONE: A comparatively safe new synthetic cannabinoid receptor agonist entering the NPS market?

scientific article published on 27 December 2018

Detection and quantification of 56 new psychoactive substances in whole blood and urine by LC-MS/MS.

artículo científico publicado en 2015

Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples

artículo científico publicado en 2017

Genotoxic properties of XLR-11, a widely consumed synthetic cannabinoid, and of the benzoyl indole RCS-4.

scientific article published on 08 February 2016

Immunoassay screening in urine for synthetic cannabinoids - an evaluation of the diagnostic efficiency.

artículo científico publicado en 2017

In vitro metabolism of the synthetic cannabinoid 3,5-AB-CHMFUPPYCA and its 5,3-regioisomer and investigation of their thermal stability.

artículo científico publicado en 2016

Investigations of the genotoxic properties of two synthetic cathinones (3-MMC, 4-MEC) which are used as psychoactive drugs

artículo científico publicado en 2016

Metabolites of synthetic cannabinoids in hair--proof of consumption or false friends for interpretation?

scientific article published on 02 March 2016

Method validation and preliminary pharmacokinetic studies on the new designer stimulant 3-fluorophenmetrazine (3-FPM)

scientific article published on 20 March 2019

Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.

artículo científico publicado en 2016

Reply to 'Sudden Cardiac Death Following Use of the Synthetic Cannabinoid MDMB-CHMICA'.

artículo científico publicado en 2016

Separation and structural characterization of the new synthetic cannabinoid JWH-018 cyclohexyl methyl derivative "NE-CHMIMO" using flash chromatography, GC-MS, IR and NMR spectroscopy

artículo científico publicado en 2016

Structural characterization and pharmacological evaluation of the new synthetic cannabinoid CUMYL-PEGACLONE.

artículo científico publicado en 2017

[Desoxypipradrol - a new (already well known) designer drug]

artículo científico publicado en 2016

Lista de obras de

Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.

Adverse effects after the use of JWH-210 - a case series from the EU Spice II plus project.

Bad trip due to 25I-NBOMe: a case report from the EU project SPICE II plus

Characterization and in vitro phase I microsomal metabolism of designer benzodiazepines: An update comprising flunitrazolam, norflurazepam, and 4'-chlorodiazepam (Ro5-4864)

Cumyl-PEGACLONE: A comparatively safe new synthetic cannabinoid receptor agonist entering the NPS market?

Detection and quantification of 56 new psychoactive substances in whole blood and urine by LC-MS/MS.

Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples

Genotoxic properties of XLR-11, a widely consumed synthetic cannabinoid, and of the benzoyl indole RCS-4.

Immunoassay screening in urine for synthetic cannabinoids - an evaluation of the diagnostic efficiency.

In vitro metabolism of the synthetic cannabinoid 3,5-AB-CHMFUPPYCA and its 5,3-regioisomer and investigation of their thermal stability.

Investigations of the genotoxic properties of two synthetic cathinones (3-MMC, 4-MEC) which are used as psychoactive drugs

Metabolites of synthetic cannabinoids in hair--proof of consumption or false friends for interpretation?

Method validation and preliminary pharmacokinetic studies on the new designer stimulant 3-fluorophenmetrazine (3-FPM)

Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.

Reply to 'Sudden Cardiac Death Following Use of the Synthetic Cannabinoid MDMB-CHMICA'.

Separation and structural characterization of the new synthetic cannabinoid JWH-018 cyclohexyl methyl derivative "NE-CHMIMO" using flash chromatography, GC-MS, IR and NMR spectroscopy

Structural characterization and pharmacological evaluation of the new synthetic cannabinoid CUMYL-PEGACLONE.

[Desoxypipradrol - a new (already well known) designer drug]